Hu, X., Jiang, B., Lu, H., Zhu, L., Chen, X., Yi, B., Wang, Z., Liu, Y., Lu, P., Zhang, M., Kong, D., Liu, B., Zhang, X., Sun, M., Cui, X., Yu, B., Li, S., Wang, Y., Zhu, W., Wang, G. (2026). Liposomal irinotecan combined with 5-FU/LV and bevacizumab as second-line therapy for metastatic colorectal cancer: A multicenter, single-arm phase II study (IRIS).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15569